Over 600 Cleansweep Auctions End Today - Bid Now
Over 1050 New Jersey Auctions End Tomorrow 06/14 - Bid Now

Elekta gets FDA clearance for Harmony radiotherapy system

Press releases may be edited for formatting or style | June 17, 2021 Rad Oncology

Harmony will provide enhanced:

Productivity: the new FastTrack in-room experience reduces patient setup time by as much as 50 percent.** Combined with further workflow enhancements, treatment slots can be reduced by up to 25 percent**, enabling clinicians to deliver high-quality cancer care to more patients.
Precision: a best-in-class multi-leaf collimator provides one-millimeter resolution beam-shaping across the full 40 cm X 40 cm field size, which provides “shrink-wrapped” sub-millimeter conformality around the tumor target.
Versatility: the option of multiple energies, treatment techniques and imaging modalities, providing the versatility needed to treat the most common indications, including breast, lung, pelvic and head-and-neck cancers.


About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

Back to HCB News

You Must Be Logged In To Post A Comment